.svg){kind=small}
Dec-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the Massachusetts market, Attune has demonstrated notable consistency in the Topical category throughout the latter part of 2024. The brand maintained its position at rank 2 in both September and October, before experiencing a slight dip to rank 4 in November and December. This movement suggests a competitive landscape where Attune remains a significant player, though not immune to fluctuations. Despite the drop in ranking, the sales figures indicate a recovery in December, with sales rising to $31,760 from a lower point in November. This rebound could imply strategic adjustments or seasonal effects influencing consumer behavior in the state.
It's also important to note that Attune's presence in other states or categories is not highlighted in the top 30 rankings, which might suggest opportunities for growth or challenges in expanding their market share beyond Massachusetts or the Topical category. The absence of rankings in other states could be viewed as a gap that Attune might need to address in order to enhance its brand visibility and performance across a broader spectrum. This focus on Massachusetts could either be a strategic choice or a limitation in their current market reach, pointing to potential areas for future development or investment.
Competitive Landscape
In the Massachusetts topical cannabis market, Attune has experienced notable fluctuations in its competitive ranking over the last few months, which could impact its sales trajectory. Attune maintained a strong position in September and October 2024, holding the second rank, but saw a decline to fourth place in November and December. This shift coincides with a decrease in sales during November, although there was a recovery in December. Competitors like Nordic Goddess and Chill Medicated have shown resilience, with Chill Medicated notably climbing from seventh to second place in December, potentially drawing sales away from Attune. Meanwhile, Avexia and The Healing Rose (THR) have remained less consistent, with Avexia not ranking in the top 20 for two months, which might offer Attune an opportunity to reclaim its higher standing if it can capitalize on these competitors' inconsistencies.
Notable Products
In December 2024, Attune's top-performing product was the CBD/THC 1:1 Muscle Freeze Lotion (75mg CBD, 75mg THC) in the Topical category, maintaining its number one rank for four consecutive months with sales of 809 units. The Muscle Freeze Lotion (100mg THC, 30ml) also held steady in second place throughout the same period, showing a consistent demand. A new entrant, the CBD/THC 1:1 Hydrating Soothing Lotion (40mg CBD, 40mg THC), debuted at rank three in December, indicating a strong initial market reception. The CBD/THC 1:1 Muscle Freeze (69mg CBD, 66mg THC) experienced a slight drop from third to fourth place, reflecting a decrease in sales over the months. Overall, Attune's product rankings have shown stability at the top, with some shifts in the lower ranks as new products enter the market.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
